Key result
Moderate or severe left-sided valve regurgitation in infective endocarditis survivors was associated with a higher 5-year risk of heart failure (28.7% vs 12.4%; HR 3.53; 95% CI 1.72-7.25).
Why the study?
Significant valve regurgitation is common after native valve infective endocarditis, but the subsequent risk of heart failure after hospital discharge is sparsely described.
Does moderate or severe left-sided valve regurgitation increase the risk of heart failure in patients surviving medically treated infective endocarditis?
Cohort (n=192)
Does moderate or severe left-sided valve regurgitation increase the risk of heart failure in patients surviving medically treated infective endocarditis?
Hazard Ratio: 3.53 (95% CI 1.72–7.25)
Absolute Event Rate: 28.7% vs 12.4%
In patients surviving medically treated infective endocarditis, moderate or severe left-sided valve regurgitation at discharge is associated with a significantly higher risk of subsequent heart failure.
Authors
No takes yet. Share an insight, caveat, or question.
Moderate to severe regurgitation after medically treated IE warrants closer HF surveillance; leaves open whether intervention improves outcomes.
Østergaard et al. (2019) conducted a cohort in native valve infective endocarditis (n=192). Moderate or severe left-sided valve regurgitation vs. No regurgitation was evaluated on Heart failure (HR 3.53, 95% CI 1.72 to 7.25). Moderate or severe left-sided valve regurgitation in infective endocarditis survivors was associated with a higher 5-year risk of heart failure (28.7% vs 12.4%; HR 3.53; 95% CI 1.72-7.25).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: